Azelaic Acid (Alvogen, Inc.)


Welcome to the PulseAid listing for the Azelaic Acid drug offered from Alvogen, Inc.. This Decreased Protein Synthesis [PE],Decreased Sebaceous Gland Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.

LABELER NAME / MANUFACTURER: Alvogen, Inc.
NON-PROPRIETARY NAME: azelaic acid
SUBSTANCE NAME: AZELAIC ACID
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Decreased Protein Synthesis [PE],Decreased Sebaceous Gland Activity [PE]
ROUTE: TOPICAL
DOSAGE FORM: GEL
MARKETING CATEGORY NAME: NDA AUTHORIZED GENERIC
START MARKETING DATE: 2015-07-08
END MARKETING DATE: 0000-00-00


Azelaic Acid HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAzelaic Acid from Alvogen, Inc.
LABELER NAME: Alvogen, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 0.15(g/g)
START MARKETING DATE: 2015-07-08
END MARKETING DATE: 0000-00-00
PRODUCT ID: 47781-447_10f4efa7-8095-450c-9731-dfaec9905076
PRODUCT NDC: 47781-447
APPLICATION NUMBER: NDA021470

Other AZELAIC ACID Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Allergan, Inc.AZELEX
Alvogen, Inc.Azelaic Acid
Bayer HealthCare Pharmaceuticals Inc.Finacea
Intendis Inc.Finacea
Physicians Total Care, Inc.Finacea